A low-dose antibiotic developed in Leiden may stop C. difficile infections more effectively by targeting the pathogen while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback